StockData
Celularity Inc logo

Celularity Inc (CELU) stock

CELUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 20, 2026Score 7/30
$0.68−0.07 (-8.81%)

Close on Nov 12, 2026Market cap $22.22MP/E –Yield –

Celularity statistics

69 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$22.22M
$280.48M
Enterprise Value
$21.64M
$148.62M
PS Ratio
1.19
3.60

Enterprise valuationIndustry

EV / Sales
1.16
2.60

Share statisticsIndustry

Shares Change (YoY)
24.6%
10.9%
Shares Change (QoQ)
0.36%
0.48%
Shares Held by Institutions
6.78%
56.4%

Short sellingIndustry

Short Interest
534,811
–
Short Interest Change
21.1%
-0.76%
Short % of Shares Outstanding
1.65%
6.30%
Days to Cover
2.33
5.13

Stock price statisticsIndustry

52-Week High
$2.55
–
52-Week Low
$0.56
–
20-Day Moving Average
$0.88
–
50-Day Moving Average
$1.20
–
200-Day Moving Average
$1.06
–
Average True Range (14)
$0.12
–
Price Change (1 Week)
-5.58%
1.51%
Price Change (1 Month)
-47.7%
-2.37%
Price Change (3 Months)
-1.58%
-21.1%
Price Change (6 Months)
-15.6%
-22.8%
Price Change (YTD)
-38.3%
-22.6%
Price Change (1 Year)
-60.2%
-21.0%
Price Change (3 Years)
-68.7%
-24.8%
Price Change (5 Years)
-99.0%
-76.9%
Average Volume (10 Days)
109,343
–
Average Volume (20 Days)
174,813
–
Average Volume (90 Days)
3M
–
Relative Volume
0.04
0.80
Relative Strength Index (14)
34.3
44.7
Volatility (1 Year)
170.2%
80.2%
Beta (5 Years)
1.95
1.07

MarginsIndustry

Gross Margin
19.2%
53.0%
Operating Margin
-264.3%
-38.5%
Pretax Margin
-245.7%
-11.8%
Profit Margin
-245.7%
-31.7%
EBITDA Margin
-228.0%
-27.7%

Returns on capitalIndustry

Return on Assets (ROA)
-42.4%
-40.7%
Return on Capital Employed (ROCE)
-135.4%
-38.1%

Financial positionIndustry

Current Ratio
0.11
3.31
Quick Ratio
0.09
2.41

GrowthIndustry

Revenue Growth (YoY)
-58.1%
7.26%
Revenue Growth (3Y CAGR)
13.9%
2.25%
Revenue Growth (5Y CAGR)
13.2%
6.41%

EfficiencyIndustry

Asset Turnover
0.17
0.40
Inventory Turnover
5.88
2.73
Revenue Per Employee
$162.31K
$429.38K
Profits Per Employee
-$398.77K
-$683.67K
Employee Count
115
75
WACC
14.6%
10.0%

Income statement (TTM)Industry

Revenue
$18.67M
$66.69M
Gross Profit
$3.59M
$116.10M
Operating Income
-$49.33M
-$20.99M
Pretax Income
-$45.86M
-$13.23M
Net Income
-$45.86M
-$21.61M
EBITDA
-$42.57M
-$16.85M
EPS (Diluted)
-$1.70
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$586.00K
$16.98M
Net Cash Per Share
$0.02
$0.72
Equity (Book Value)
-$35.53M
$52.68M
Book Value Per Share
-$1.09
$1.50
Tangible Book Value
-$49.21M
$26.74M
Working Capital
-$53.29M
$78.52M

Cash flow (TTM)Industry

Operating Cash Flow
-$8.92M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-206.4%
-21.0%

Scores and fair valueIndustry

Altman Z-Score
-16.47
0.26
Piotroski F-Score
1
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodCELUS&P 500DifferenceCELU per yearS&P 500 per year
1 month-53.4%-2.7%−50.7 pts
3 months-0.8%-1.7%+1.0 pts
Year to date-38.3%+11.9%−50.2 pts
1 year-59.2%+12.0%−71.2 pts
3 years-68.7%+78.2%−146.9 pts-32.1%+21.2%
5 years-99.0%+73.2%−172.3 pts-60.5%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

1M CELU shares were sold short on Oct 30, 2026, up 21.1% from the previous report. At recent volumes it would take 2.3 days to buy them back. Over the last 20 sessions, 54.8% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 2026534,811+21.1%229,8942.3
Oct 15, 2026441,798+12.9%120,7483.7
Sep 30, 2026391,276-52.3%154,9292.5
Sep 15, 2026821,020-56.7%393,5532.1
Aug 31, 20261,897,722+370.2%21,797,6281.0
Aug 14, 2026403,568+3.3%25,59715.8
Jul 31, 2026390,836-6.8%51,0127.7
Jul 15, 2026419,533+1.5%146,9772.9
Jun 30, 2026413,401+10.2%124,5083.3
Jun 15, 2026374,988+8.6%169,9832.2
May 29, 2026345,339-7.5%159,3242.2
May 15, 2026373,196+35.5%281,4111.3

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?